T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 5020-5028

  Sharma, Sherven ^a   Stolina, Marina ^a   Lin, Ying ^a   Gardner, Brian ^a   Miller, Patrice W ^a   Kronenberg, Mitchell ^c   Dubinett, Steven M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; LEWIS CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TUMOR CELLS, CULTURED;

EID: 0032709778     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Dubinett, S. M., and R. L. Kradin. 1993. Cytokine immunotherapy of non-small cell lung cancer. Reg. Immunol. 5:232.
2. Yoshino, I., T. Yano, M. Murata, T. Ishida, K. Sugimachi, G. Kimura, and K. Nomoto. 1992. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res. 52:775.
3. Huang, M., J. Wang, P. Lee, S. Sharma, J. T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman, and S. M. Dubinett. 1995. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55:3847.
4. Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J. Immunol. 155:2240.
5. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. Ogarra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
6. Mitra, R. S., T. A. Judge, F. O. Nestle, L. A. Turka, and B. J. Nickoloff. 1995. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. J. Immunol. 154:2668.
7. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143.
8. De Waal-Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. Te Velde, C. Fidgor, K. Johnson, R. Kastelein, H. Yssel, and J. E. De Vries. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class-II major histocompatibility complex expression. J. Exp. Med 174:915.
9. Mosmann, T., and K. W. Moore. 1991. The role of IL-10 in cross-regulation of TH1 and TH2 responses. Immunol. Today 12:A49.
10. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. 7. Immunol. 146:3444.
11. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol. 157:5512.
12. Hagenbaugh, A., S. Sharma, S. Dubinett, S. H.-Y. Wei, R. Aranda, H. Cheroutre, D. Fowell, S. Binder, B. Tsao, R. Locksley, et al. 1997. Altered immune responses in IL-10 transgenic mice. J. Exp. Med. 185:2101.
13. Dubinett, S. M., J. T. Kurnick, and R. L. Kradin. 1989. Adoptive immunotherapy of murine pulmonary metastases with interleukin 2 and interferon-γ. Am. J. Respir. Cell Mol. Biol. 1:361.
14. Sharma, S., P. Miller, M. Stolina, L. Zhu, M. Huang, R. Paul, and S. Dubinett. 1997. Multi-component gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin 7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo-activated dendritic cells. Gene Ther. 4:1361.
15. Morikane, K., R. Tempero, C. Sivinski, M. Nomoto, M. Van Lith, T. Muto, and M. Hollingsworth. 1999. Organ-specific pancreatic tumor growth properties and tumor immunity. Cancer Immunol. Immunother. 47:287.
16. Rohrer, J. W., and J. H. Coggin Jr. 1995. CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J. Immunol. 155:5719.
17. Stolina, M., S. Sharma, M. Huang, Y. Lin, L. Zhu, K. Chen, K. Lim, P. Miller, and S. Dubinett. 1997. Tumor cyclooxygenase-dependent modulation of lymphocyte IL-10 production in murine lung cancer. Proc. Am. Assoc. Cancer Res. 38:121.
18. O'Hara, R. J., J. Greenman, P. J. Drew, A. W. McDonald, G. S. Duthie, P. W. Lee, and J. R. Monson. 1998. Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer. Dis. Colon Rectum 41:460.
19. O'Hara, R. J., J. Greenman, A. W. McDonald, K. M. Gaskell, K. P. Topping, G. S. Duthie, M. J. Kerin, P. W. Lee, and J. R. Monson. 1998. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin. Cancer Res. 4:1943.
20. Asselin-Paturel, C., H. Echchakir, G. Carayol, F. Gay, P. Opolon, D. Grunenwald, S. Chouaib, and F. Mami-Chouaib. 1998. Quantitative analysis of Th1, Th2 and TGF-β1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int. J. Cancer 77:7.
21. Yamamura, M., R. L. Modlin, J. D. Ohmen, and R. L. Moy. 1993. Local expression of anti-inflammatory cytokines in cancer. J. Clin. Invest. 91:1005.
22. Ghosh, P., K. L. Komschlies, M. Cippitelli, D. L. Longo, J. Subleski, J. Ye, A. Sica, H. A. Young, R. H. Wiltrout, and A. C. Ochoa. 1995. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. Natl. Cancer Inst. 87:1478.
23. Assenmacher, M., M. Lohning, A. Scheffold, R. Manz, J. Schmitz, and A. Radbruch. 1998. Sequential production of IL-2, IFN-γ and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur. J. Immunol. 28:1534.
24. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood 81:2964.
25. Ding, L., and E. Shevach. 1992. IL-10 inhibits mitogen-induced T-cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133.
26. Ding, L., P. Linsley, L. Huang, R. Germain, and E Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
27. Bejarano, M. T., R. De Waal Malefyt, J. S. Abrams, M. Bigler, R. Baccheta, J. E. De Vries, and M. G. Roncarolo. 1992. Interleukin-10 inhibits allogenic proliferative and cytotoxic T-cell responses generated in primary mixed lymphocyte cultures. Int. Immunol. 4:1389.
28. + cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182.
29. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
30. Qin, Z., G. Noffz, M. Mohaupt, and T. Blankenstein. 1997. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159:770.
31. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
32. Allavena, P., L. Piemonti, D. Longoni, S. Bernasconi, A. Stoppacciaro, L. Ruco, and A. Mantovani. 1998. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28: 359.
33. + T cells to secrete IL-4. Adv. Exp. Med. Biol. 417:375.
34. Macatonia, S., T. Doherty, S. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J. Immunol. 150:3755.
35. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
36. Ludewig, B., D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek, and G. Pauli. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1943.
37. Kobayashi, M., H. Kobayashi, R. Pollard, and F. Suzuki. 1998. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J. Immunol. 160:5869.
38. Huang, M., M. Stolina, S. Sharma, J. Mao, L. Zhu, P. Miller, J. Wollman, H. Herschman, and S. Dubinett. 1998. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58:1208.
39. Murray, P., L. Wang, C. Onufryk, R. Tepper, and R. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315.
40. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
41. Florquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618.
42. Bean, A. G., R. A. Freiberg, S. Andrade, S. Menon, and A. Zlotnik. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61:4937.
43. Chang, C., M. Furue, and K. Tamaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by inierleukin-10. Eur. J. Immunol. 25:394.
44. Salazar-Onfray, F., J. Charo, M. Petersson, S. Freland, G. Noffz, Z. Qin, T. Blankenstein, H. G. Ljunggren, and R. Kiessling. 1997. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. J. Immunol. 159:3/95.
45. Petersson, M., J. Charo, F. Salazar-Onfray, G. Noffz, M. Mohaupt, Z. Qin, G. Klein, T. Blankenstein, and R. Kiessling. 1998. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J. Immunol. 161:2099.
46. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2:1096.
47. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. Deleo, and M. T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1:1297.
48. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peplide-pulsed dendritic cells induce antigen-specific. CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
49. Hsu, F., C. Benike, F. Fagnoni, T. Liles, D. Czerwinski, B. Taidi, E. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52.
50. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229.
51. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q. Zhang, M. G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and down-regulates HLA class I expression. J. Exp. Med. 180:2371.
52. Salazar-Onfray, F., M. Petersson, L. Franksson, M. Matsuda, T. Blankenstein, K. Karre, and R. Kiessling. 1995. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol. 154:6291.
53. Pisa, P., E. Halapi, E. K. Pisa, E. Gerdin, C. Hising, A. Bucht, B. Gerdin, and R. Kiessling. 1992. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA 89:7708.
54. Wang, L., E. Goillot, and R. I. Tepper. 1994. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol. 159:152.
55. Giovarelli, M., P. Musiani, A. Modesli, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. Di Pierro, C. De Giovanni, et al. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155:3112.
56. Suzuki, T., H. Tahara, S. Narula, K. W. Moore, P. D. Robbins, and M. T. Lotze. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477.
57. Richter, G., S. Kruger-Krasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein, and T. Blankenstein. 1993. Inlerleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53:4134.
58. Oraux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M.-G. Roncarolo, and R. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162:1723.
59. Chen, W. F., and A. Zlotnik. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147:528.
60. Yano, S., H. Yanagawa, Y. Nishioka, N. Mukaida, K. Matsushima, and S. Sone. 1996. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J. Immunol. 157:2660.
61. Yang, G., K. E. Hellstrom, M. T. Mizuno, and L. Chen. 1995. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J. Immunol. 155:3897.
62. MacNeil, I. A., T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlolnik. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145:4167.
63. + T cells. J. Immunol. 160:3188.